Elsa Renee Flores
553 posts

Elsa Renee Flores
@LabElsaFlores
Moffitt Cancer Center ACD & Division Chief, Basic Science. Cancer Biologist. Discovery Science.
Tampa, FL Katılım Şubat 2020
1.1K Takip Edilen745 Takipçiler

Enjoyed spending time with @MoffittNews Drug Discovery team during our latest listening tour.
It’s exciting to hear about the work underway to identify new cancer targets, develop promising small molecule therapies and move discoveries from the lab toward the clinic.
@StuartMaudsley @monastyrskyi @LopchukLab @karenluMD #CancerResearch #CancerTherapeutics #TranslationalResearch

English
Elsa Renee Flores retweetledi

From the Moffitt booth at #AACR26, insights from Elsa Flores, PhD (@LabElsaFlores), and Brian Ruffell, PhD (@Ruffell_Lab), on how tumor cells may evade immune recognition through surface molecules, particularly in genomically unstable breast cancers. #MoffittAACR26 @AACR
English
Elsa Renee Flores retweetledi

From the floor at #AACR26, a conversation between Elsa Flores, PhD (@LabElsaFlores), and Chang Jiang, PhD (@ChangJiangLab), on how cancer metabolism research, including dendritic cell metabolism, may enhance immune responses and improve therapies like CAR T-cell treatment. #MoffittAACR26 @AACR
English
Elsa Renee Flores retweetledi

While at #AACR26, Elsa Flores, PhD (@LabElsaFlores), and Florian Karreth, PhD (@KarrethLab), took some time to discuss how non-genetic events drive melanoma progression and how new rapid preclinical models are helping accelerate cancer research. #MoffittAACR26 @AACR
English
Elsa Renee Flores retweetledi

Earlier at #AACR26, Elsa Flores, PhD (@LabElsaFlores), and Andrii Monastyrskyi, PhD, took a moment to discuss how emerging drug discovery approaches, including protein degradation and AI-driven design, are advancing new cancer therapies. #MoffittAACR26 @AACR
English

@PatrickHwuMD @MoffittNews @KarrethLab @JenBinning Thank you for coming to our labs and talking to everyone about their research. It was an inspiring morning!
English

Listening and learning with our Molecular Oncology team @MoffittNews this morning! Appreciated hearing from our faculty and trainees and visiting @KarrethLab, @LabElsaFlores and @JenBinning’s lab to check out some of the experiments in progress. #ListeningTour #LeadershipByWalkingAround




English

Had a memorable and exciting day celebrating Moffitt Cancer Center and the Moffitt Discovery and Innovation Center! Thank you to @TsoiKobus and @WhitingTurner !! @MoffittNews @Timadams2023 @PatrickHwuMD @HLeeMoffitt1


English

Proud dad moment: my daughter Julie is at the @Olympics competing in speed skating. The persistence and unwavering dedication it takes to reach this level is extraordinary. You've got this! 🇺🇸 nbcolympics.com/news/how-julie…
English
Elsa Renee Flores retweetledi

Thrilled to share our deconstruction of a p53 therapeutic response in #LUAD- a step toward drugging #undruggable #p53! Thanks to our amazing team! @wmx162005 @alyssamkaiser @kbieging @LabElsaFlores @MikeOzawa @MLadanyi @arati_rajeevan @rajnitin @simone_alma
Cancer Discovery@CD_AACR
Now online: p53 Drives Lung Cancer Regression through a TSC2/TFEB-Dependent Senescence Program doi.org/10.1158/2159-8…
English

This morning, I was thrilled to show off the progress on the Moffitt Discovery and Innovation Center at SPEROS. I can’t wait to make new discoveries with my colleagues using trans disciplinary approaches. Big thank you to @PatrickHwuMD @HLeeMoffitt1 @john Cleveland for the opportunity to lead this effort! @MoffittNews




English
Elsa Renee Flores retweetledi

James V. DeGregori, Emilia Lim, William Hill, and Kenneth Y. Tsai discussed "Early Events and Clonal Origins" in a plenary session at the AACR Special Conference on Cancer Evolution.
#AACRevol25 @LimEmilia @DrWilliamHill @KYTsaiLab

English

A pioneer and an inspiration!
In Conversation with Robert S. Langer | ACS Nano Medicine pubs.acs.org/doi/10.1021/ac…
English

Great day at Miles for Moffitt with my team Research Rangers and my daughter, Athena! @MoffittNews @PatrickHwuMD @HLeeMoffitt1


English
Elsa Renee Flores retweetledi

At #SITC25, Kenneth Tsai, MD (@KYTsaiLab), presents Phase II results showing a 57.7% pCR with neoadjuvant lenvatinib plus pembrolizumab in stage II–IV Merkel cell carcinoma. Responders show interferon and ANGPTL1 signaling; nonresponders show neural and E2F/MYC pathways with higher baseline Tregs. #MoffittSITC25
English

Highlights from the Jaeger Lab at SITC!
Moffitt Cancer Center@MoffittNews
Tomorrow at #SITC25, Christopher Polera will share research on how RAS inhibition reshapes the tumor immunopeptidome to reveal new immunogenic targets and inform combination immunotherapy strategies. #MoffittSITC25 @sitcancer
English
Elsa Renee Flores retweetledi

Live from #SITC25: Kenneth Tsai, MD (@KYTsaiLab) presents data showing that Pembrolizumab plus Levatinib demonstrated encouraging efficacy as neoadjuvant therapy for resectable clinical stage II-IV Merkel cell carcinoma.



English
Elsa Renee Flores retweetledi

Tomorrow at #SITC25: Kenneth Tsai, MD, PhD (@KYTsaiLab) presents a late-breaking abstract on the molecular and immunologic correlates of response in the phase II study of neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma.
#MoffittSITC25 @sitcancer

English


